nodes	percent_of_prediction	percent_of_DWPC	metapath
Allylestrenol—PGR—uterine cancer	0.196	0.613	CbGaD
Allylestrenol—ESR1—uterine cancer	0.124	0.387	CbGaD
Allylestrenol—PGR—Medroxyprogesterone Acetate—uterine cancer	0.11	0.337	CbGbCtD
Allylestrenol—ESR1—Medroxyprogesterone Acetate—uterine cancer	0.076	0.234	CbGbCtD
Allylestrenol—PGR—Progesterone—uterine cancer	0.0726	0.223	CbGbCtD
Allylestrenol—Ethynodiol—Medroxyprogesterone Acetate—uterine cancer	0.0551	0.176	CrCrCtD
Allylestrenol—ESR1—Progesterone—uterine cancer	0.0504	0.155	CbGbCtD
Allylestrenol—Norgestimate—Progesterone—uterine cancer	0.048	0.153	CrCrCtD
Allylestrenol—Oxandrolone—Progesterone—uterine cancer	0.048	0.153	CrCrCtD
Allylestrenol—Ethynodiol—Progesterone—uterine cancer	0.048	0.153	CrCrCtD
Allylestrenol—Levonorgestrel—Progesterone—uterine cancer	0.0355	0.113	CrCrCtD
Allylestrenol—Norethindrone—Progesterone—uterine cancer	0.0285	0.0909	CrCrCtD
Allylestrenol—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.0268	0.0856	CrCrCtD
Allylestrenol—Methyltestosterone—Progesterone—uterine cancer	0.0234	0.0746	CrCrCtD
Allylestrenol—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00781	0.024	CbGbCtD
Allylestrenol—PGR—corpus luteum—uterine cancer	0.00775	0.293	CbGeAlD
Allylestrenol—CYP3A4—Progesterone—uterine cancer	0.00517	0.0159	CbGbCtD
Allylestrenol—PGR—oviduct—uterine cancer	0.00266	0.101	CbGeAlD
Allylestrenol—CYP3A4—Etoposide—uterine cancer	0.00231	0.00711	CbGbCtD
Allylestrenol—ESR1—oviduct—uterine cancer	0.00208	0.0787	CbGeAlD
Allylestrenol—PGR—artery—uterine cancer	0.00176	0.0666	CbGeAlD
Allylestrenol—CYP3A4—Doxorubicin—uterine cancer	0.00158	0.00485	CbGbCtD
Allylestrenol—PGR—myometrium—uterine cancer	0.000852	0.0322	CbGeAlD
Allylestrenol—PGR—epithelium—uterine cancer	0.000669	0.0253	CbGeAlD
Allylestrenol—ESR1—myometrium—uterine cancer	0.000667	0.0252	CbGeAlD
Allylestrenol—PGR—uterine cervix—uterine cancer	0.000663	0.0251	CbGeAlD
Allylestrenol—PGR—smooth muscle tissue—uterine cancer	0.000645	0.0244	CbGeAlD
Allylestrenol—PGR—decidua—uterine cancer	0.000632	0.0239	CbGeAlD
Allylestrenol—PGR—endometrium—uterine cancer	0.0006	0.0227	CbGeAlD
Allylestrenol—PGR—uterus—uterine cancer	0.000553	0.0209	CbGeAlD
Allylestrenol—ESR1—epithelium—uterine cancer	0.000523	0.0198	CbGeAlD
Allylestrenol—ESR1—uterine cervix—uterine cancer	0.000519	0.0196	CbGeAlD
Allylestrenol—ESR1—smooth muscle tissue—uterine cancer	0.000504	0.019	CbGeAlD
Allylestrenol—PGR—female reproductive system—uterine cancer	0.000497	0.0188	CbGeAlD
Allylestrenol—ESR1—decidua—uterine cancer	0.000494	0.0187	CbGeAlD
Allylestrenol—ESR1—renal system—uterine cancer	0.000485	0.0183	CbGeAlD
Allylestrenol—ESR1—endometrium—uterine cancer	0.000469	0.0177	CbGeAlD
Allylestrenol—PGR—Ovarian Infertility Genes—MLH1—uterine cancer	0.000454	0.0366	CbGpPWpGaD
Allylestrenol—PGR—female gonad—uterine cancer	0.000452	0.0171	CbGeAlD
Allylestrenol—PGR—vagina—uterine cancer	0.00045	0.017	CbGeAlD
Allylestrenol—ESR1—uterus—uterine cancer	0.000432	0.0163	CbGeAlD
Allylestrenol—ESR1—female reproductive system—uterine cancer	0.000389	0.0147	CbGeAlD
Allylestrenol—PGR—Ovarian Infertility Genes—ESR2—uterine cancer	0.000379	0.0305	CbGpPWpGaD
Allylestrenol—ESR1—female gonad—uterine cancer	0.000354	0.0134	CbGeAlD
Allylestrenol—ESR1—vagina—uterine cancer	0.000352	0.0133	CbGeAlD
Allylestrenol—PGR—Ovarian Infertility Genes—CYP19A1—uterine cancer	0.000344	0.0277	CbGpPWpGaD
Allylestrenol—Ethynodiol—PGR—uterine cancer	0.000342	0.123	CrCbGaD
Allylestrenol—PGR—Nuclear Receptors—ESR2—uterine cancer	0.00033	0.0266	CbGpPWpGaD
Allylestrenol—Norelgestromin—PGR—uterine cancer	0.000323	0.116	CrCbGaD
Allylestrenol—Desogestrel—PGR—uterine cancer	0.000311	0.112	CrCbGaD
Allylestrenol—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.000303	0.0244	CbGpPWpGaD
Allylestrenol—Norgestimate—PGR—uterine cancer	0.000291	0.105	CrCbGaD
Allylestrenol—PGR—lymph node—uterine cancer	0.000291	0.011	CbGeAlD
Allylestrenol—PGR—Ovarian Infertility Genes—SMAD3—uterine cancer	0.000281	0.0227	CbGpPWpGaD
Allylestrenol—CYP3A4—renal system—uterine cancer	0.000271	0.0102	CbGeAlD
Allylestrenol—Quinestrol—ESR1—uterine cancer	0.000262	0.0944	CrCbGaD
Allylestrenol—PGR—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.000261	0.021	CbGpPWpGaD
Allylestrenol—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.000233	0.0188	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—NFE2L2—uterine cancer	0.000232	0.0187	CbGpPWpGaD
Allylestrenol—ESR1—lymph node—uterine cancer	0.000227	0.00859	CbGeAlD
Allylestrenol—ESR1—Nuclear Receptors—PGR—uterine cancer	0.00022	0.0177	CbGpPWpGaD
Allylestrenol—PGR—Validated nuclear estrogen receptor alpha network—ESR2—uterine cancer	0.000217	0.0175	CbGpPWpGaD
Allylestrenol—CYP3A4—female reproductive system—uterine cancer	0.000217	0.00819	CbGeAlD
Allylestrenol—Ethynodiol—ESR1—uterine cancer	0.000216	0.0778	CrCbGaD
Allylestrenol—ESR1—Nuclear signaling by ERBB4—PGR—uterine cancer	0.000215	0.0174	CbGpPWpGaD
Allylestrenol—ESR1—Signaling events mediated by HDAC Class II—YWHAE—uterine cancer	0.00021	0.0169	CbGpPWpGaD
Allylestrenol—PGR—Nuclear Receptors—ESR1—uterine cancer	0.0002	0.0161	CbGpPWpGaD
Allylestrenol—Desogestrel—ESR1—uterine cancer	0.000196	0.0707	CrCbGaD
Allylestrenol—PGR—Nuclear signaling by ERBB4—ESR1—uterine cancer	0.000196	0.0158	CbGpPWpGaD
Allylestrenol—ESR1—Nuclear Receptors—ESR2—uterine cancer	0.000194	0.0156	CbGpPWpGaD
Allylestrenol—ESR1—LKB1 signaling events—YWHAE—uterine cancer	0.00019	0.0153	CbGpPWpGaD
Allylestrenol—Norgestimate—ESR1—uterine cancer	0.000184	0.0661	CrCbGaD
Allylestrenol—ESR1—Plasma membrane estrogen receptor signaling—ESR2—uterine cancer	0.000182	0.0147	CbGpPWpGaD
Allylestrenol—Levonorgestrel—PGR—uterine cancer	0.000178	0.0641	CrCbGaD
Allylestrenol—ESR1—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.000174	0.014	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.00016	0.0129	CbGpPWpGaD
Allylestrenol—ESR1—LKB1 signaling events—STK11—uterine cancer	0.000159	0.0128	CbGpPWpGaD
Allylestrenol—PGR—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.000158	0.0127	CbGpPWpGaD
Allylestrenol—PGR—Ovarian Infertility Genes—CDKN1B—uterine cancer	0.000156	0.0126	CbGpPWpGaD
Allylestrenol—ESR1—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.000153	0.0123	CbGpPWpGaD
Allylestrenol—ESR1—Validated nuclear estrogen receptor alpha network—PGR—uterine cancer	0.000145	0.0117	CbGpPWpGaD
Allylestrenol—Norethindrone—PGR—uterine cancer	0.000144	0.052	CrCbGaD
Allylestrenol—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—uterine cancer	0.000144	0.0116	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of Telomerase—IRF1—uterine cancer	0.000141	0.0114	CbGpPWpGaD
Allylestrenol—PGR—Validated nuclear estrogen receptor alpha network—ESR1—uterine cancer	0.000132	0.0106	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of Telomerase—YWHAE—uterine cancer	0.000132	0.0106	CbGpPWpGaD
Allylestrenol—ESR1—Validated nuclear estrogen receptor alpha network—ESR2—uterine cancer	0.000128	0.0103	CbGpPWpGaD
Allylestrenol—ESR1—FOXM1 transcription factor network—BIRC5—uterine cancer	0.000126	0.0101	CbGpPWpGaD
Allylestrenol—Levonorgestrel—CYP19A1—uterine cancer	0.000122	0.044	CrCbGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—SOCS3—uterine cancer	0.000116	0.00933	CbGpPWpGaD
Allylestrenol—Levonorgestrel—ESR1—uterine cancer	0.000112	0.0405	CrCbGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—MSH6—uterine cancer	0.000105	0.00848	CbGpPWpGaD
Allylestrenol—ESR1—Leptin signaling pathway—SOCS3—uterine cancer	9.56e-05	0.0077	CbGpPWpGaD
Allylestrenol—Methyltestosterone—CYP19A1—uterine cancer	9.4e-05	0.0339	CrCbGaD
Allylestrenol—ESR1—Regulation of Telomerase—SMAD3—uterine cancer	9.04e-05	0.00728	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	8.95e-05	0.00721	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—uterine cancer	8.6e-05	0.00694	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—MSH2—uterine cancer	8.54e-05	0.00688	CbGpPWpGaD
Allylestrenol—ESR1—FOXM1 transcription factor network—CDKN2A—uterine cancer	8.32e-05	0.00671	CbGpPWpGaD
Allylestrenol—PGR—Validated nuclear estrogen receptor alpha network—EP300—uterine cancer	7.87e-05	0.00635	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—SMAD3—uterine cancer	7.86e-05	0.00633	CbGpPWpGaD
Allylestrenol—ESR1—Estrogen signaling pathway—PIK3CA—uterine cancer	7.75e-05	0.00625	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—FGFR2—uterine cancer	7.72e-05	0.00622	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—PGR—uterine cancer	7.26e-05	0.00585	CbGpPWpGaD
Allylestrenol—ESR1—FOXA1 transcription factor network—CDKN1B—uterine cancer	7.1e-05	0.00572	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—PHF1—uterine cancer	6.94e-05	0.0056	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	6.85e-05	0.00552	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—ESR1—uterine cancer	6.6e-05	0.00532	CbGpPWpGaD
Allylestrenol—ESR1—FOXM1 transcription factor network—EP300—uterine cancer	6.47e-05	0.00522	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—CCL2—uterine cancer	6.34e-05	0.00511	CbGpPWpGaD
Allylestrenol—ESR1—Estrogen signaling pathway—AKT1—uterine cancer	6.33e-05	0.0051	CbGpPWpGaD
Allylestrenol—ESR1—FOXA1 transcription factor network—EP300—uterine cancer	6.24e-05	0.00503	CbGpPWpGaD
Allylestrenol—ESR1—Plasma membrane estrogen receptor signaling—NRAS—uterine cancer	6.17e-05	0.00497	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—EP300—uterine cancer	6.02e-05	0.00485	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—CHD4—uterine cancer	5.9e-05	0.00476	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—CYP19A1—uterine cancer	5.83e-05	0.0047	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—STK11—uterine cancer	5.83e-05	0.0047	CbGpPWpGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—CXCL8—uterine cancer	5.75e-05	0.00463	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	5.74e-05	0.00463	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	5.7e-05	0.00459	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	5.63e-05	0.00454	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—CDKN2A—uterine cancer	5.53e-05	0.00446	CbGpPWpGaD
Allylestrenol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	5.41e-05	0.00436	CbGpPWpGaD
Allylestrenol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—uterine cancer	5.36e-05	0.00432	CbGpPWpGaD
Allylestrenol—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	5.34e-05	0.0043	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	5.32e-05	0.00429	CbGpPWpGaD
Allylestrenol—ESR1—Plasma membrane estrogen receptor signaling—KRAS—uterine cancer	5.31e-05	0.00428	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—CXCL8—uterine cancer	5.02e-05	0.00404	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of Telomerase—CDKN1B—uterine cancer	5.01e-05	0.00404	CbGpPWpGaD
Allylestrenol—ESR1—Leptin signaling pathway—ERBB2—uterine cancer	5e-05	0.00403	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—SUZ12—uterine cancer	4.95e-05	0.00399	CbGpPWpGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—EP300—uterine cancer	4.93e-05	0.00397	CbGpPWpGaD
Allylestrenol—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	4.92e-05	0.00397	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—CDKN1B—uterine cancer	4.9e-05	0.00395	CbGpPWpGaD
Allylestrenol—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—uterine cancer	4.88e-05	0.00393	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—ERBB2—uterine cancer	4.85e-05	0.00391	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	4.85e-05	0.00391	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	4.83e-05	0.00389	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—CTNNB1—uterine cancer	4.63e-05	0.00373	CbGpPWpGaD
Allylestrenol—ESR1—Validated nuclear estrogen receptor alpha network—EP300—uterine cancer	4.62e-05	0.00372	CbGpPWpGaD
Allylestrenol—ESR1—LKB1 signaling events—TP53—uterine cancer	4.55e-05	0.00366	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—FGFR2—uterine cancer	4.53e-05	0.00365	CbGpPWpGaD
Allylestrenol—ESR1—Plasma membrane estrogen receptor signaling—HRAS—uterine cancer	4.52e-05	0.00364	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—PTEN—uterine cancer	4.51e-05	0.00363	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—ESR2—uterine cancer	4.5e-05	0.00363	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—CDKN1B—uterine cancer	4.49e-05	0.00362	CbGpPWpGaD
Allylestrenol—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	4.38e-05	0.00353	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	4.33e-05	0.00349	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—EP300—uterine cancer	4.3e-05	0.00347	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—PTEN—uterine cancer	4.13e-05	0.00333	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	4.13e-05	0.00333	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	4.12e-05	0.00332	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—PHF1—uterine cancer	4.07e-05	0.00328	CbGpPWpGaD
Allylestrenol—ESR1—Plasma membrane estrogen receptor signaling—AKT1—uterine cancer	3.99e-05	0.00321	CbGpPWpGaD
Allylestrenol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	3.98e-05	0.00321	CbGpPWpGaD
Allylestrenol—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	3.93e-05	0.00316	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	3.84e-05	0.00309	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	3.83e-05	0.00308	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—NRAS—uterine cancer	3.69e-05	0.00297	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—CDKN2B—uterine cancer	3.67e-05	0.00296	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—CHD4—uterine cancer	3.46e-05	0.00279	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—CDH1—uterine cancer	3.39e-05	0.00273	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—SMAD3—uterine cancer	3.35e-05	0.0027	CbGpPWpGaD
Allylestrenol—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	3.22e-05	0.0026	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—KRAS—uterine cancer	3.17e-05	0.00256	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—AKR1B10—uterine cancer	3.13e-05	0.00252	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—TP53—uterine cancer	3.08e-05	0.00248	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—PGR—uterine cancer	3e-05	0.00242	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—PIK3CA—uterine cancer	2.92e-05	0.00235	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—SUZ12—uterine cancer	2.9e-05	0.00234	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—ERBB2—uterine cancer	2.84e-05	0.00229	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	2.82e-05	0.00227	CbGpPWpGaD
Allylestrenol—ESR1—Leptin signaling pathway—HRAS—uterine cancer	2.79e-05	0.00224	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—ESR1—uterine cancer	2.73e-05	0.0022	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—HRAS—uterine cancer	2.7e-05	0.00217	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of Telomerase—AKT1—uterine cancer	2.66e-05	0.00214	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—ESR2—uterine cancer	2.64e-05	0.00213	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—CDKN1B—uterine cancer	2.63e-05	0.00212	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—RNF43—uterine cancer	2.59e-05	0.00209	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	2.5e-05	0.00202	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	2.47e-05	0.00199	CbGpPWpGaD
Allylestrenol—ESR1—Leptin signaling pathway—AKT1—uterine cancer	2.46e-05	0.00198	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	2.44e-05	0.00197	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—PTEN—uterine cancer	2.43e-05	0.00195	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—AKT1—uterine cancer	2.38e-05	0.00192	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—INHBA—uterine cancer	2.37e-05	0.00191	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.37e-05	0.00191	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—EZH2—uterine cancer	2.34e-05	0.00189	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	2.33e-05	0.00188	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—EP300—uterine cancer	2.33e-05	0.00187	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	2.31e-05	0.00186	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	2.3e-05	0.00185	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	2.2e-05	0.00177	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.19e-05	0.00177	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—ESR2—uterine cancer	2.17e-05	0.00175	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	2.17e-05	0.00175	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—NRAS—uterine cancer	2.16e-05	0.00174	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—CDKN2B—uterine cancer	2.15e-05	0.00173	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—AKR1C1—uterine cancer	2.13e-05	0.00172	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.07e-05	0.00167	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	2.02e-05	0.00163	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—SMAD3—uterine cancer	1.96e-05	0.00158	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.93e-05	0.00155	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	1.87e-05	0.00151	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—KRAS—uterine cancer	1.86e-05	0.0015	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—AKR1B10—uterine cancer	1.84e-05	0.00148	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.82e-05	0.00147	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—CDKN2B—uterine cancer	1.77e-05	0.00142	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.71e-05	0.00138	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—PIK3CA—uterine cancer	1.71e-05	0.00138	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.69e-05	0.00136	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—TP53—uterine cancer	1.66e-05	0.00134	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—AKR1C3—uterine cancer	1.64e-05	0.00132	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—SMAD3—uterine cancer	1.61e-05	0.0013	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—HRAS—uterine cancer	1.58e-05	0.00128	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.55e-05	0.00125	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—YWHAE—uterine cancer	1.53e-05	0.00123	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—RNF43—uterine cancer	1.52e-05	0.00123	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—FBXW7—uterine cancer	1.46e-05	0.00118	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—PGR—uterine cancer	1.45e-05	0.00117	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.43e-05	0.00115	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	1.41e-05	0.00113	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—AKT1—uterine cancer	1.4e-05	0.00113	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—INHBA—uterine cancer	1.39e-05	0.00112	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.38e-05	0.00111	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—EZH2—uterine cancer	1.37e-05	0.00111	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—ESR1—uterine cancer	1.32e-05	0.00106	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—STK11—uterine cancer	1.28e-05	0.00103	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—ESR2—uterine cancer	1.27e-05	0.00103	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—AKR1C1—uterine cancer	1.25e-05	0.00101	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—SOCS3—uterine cancer	1.2e-05	0.000966	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.16e-05	0.000938	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CDKN2B—uterine cancer	1.15e-05	0.000925	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IGF1R—uterine cancer	1.11e-05	0.000898	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—SMAD3—uterine cancer	1.05e-05	0.000845	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—CDKN2B—uterine cancer	1.04e-05	0.000835	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—FGFR2—uterine cancer	1e-05	0.000806	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—AKR1C3—uterine cancer	9.65e-06	0.000777	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—SMAD3—uterine cancer	9.46e-06	0.000762	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PGR—uterine cancer	9.4e-06	0.000758	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NDUFB11—uterine cancer	9.2e-06	0.000742	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SRD5A2—uterine cancer	9.2e-06	0.000742	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—YWHAE—uterine cancer	8.97e-06	0.000723	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—FBXW7—uterine cancer	8.6e-06	0.000693	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ESR1—uterine cancer	8.55e-06	0.000689	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CCL2—uterine cancer	7.53e-06	0.000607	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—STK11—uterine cancer	7.51e-06	0.000606	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—SOCS3—uterine cancer	7.04e-06	0.000567	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CDKN2B—uterine cancer	6.74e-06	0.000543	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—AKR1B1—uterine cancer	6.65e-06	0.000536	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—STAR—uterine cancer	6.65e-06	0.000536	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IGF1R—uterine cancer	6.54e-06	0.000527	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ERBB2—uterine cancer	6.28e-06	0.000506	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—SMAD3—uterine cancer	6.15e-06	0.000496	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CXCL8—uterine cancer	5.95e-06	0.00048	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—FGFR2—uterine cancer	5.87e-06	0.000473	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CDKN1B—uterine cancer	5.81e-06	0.000469	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CTNNB1—uterine cancer	5.49e-06	0.000443	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PTEN—uterine cancer	5.35e-06	0.000431	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—POLD1—uterine cancer	5.22e-06	0.000421	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—EP300—uterine cancer	5.1e-06	0.000411	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—AKR1C1—uterine cancer	4.88e-06	0.000394	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—VEGFA—uterine cancer	4.83e-06	0.00039	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—NRAS—uterine cancer	4.78e-06	0.000385	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—AKT1—uterine cancer	4.74e-06	0.000382	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCL2—uterine cancer	4.42e-06	0.000356	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—RRM2—uterine cancer	4.35e-06	0.000351	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—DCN—uterine cancer	4.23e-06	0.000341	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—KRAS—uterine cancer	4.11e-06	0.000331	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP11A1—uterine cancer	3.98e-06	0.000321	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PIK3CA—uterine cancer	3.78e-06	0.000304	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—AKR1C3—uterine cancer	3.76e-06	0.000303	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ERBB2—uterine cancer	3.68e-06	0.000297	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TP53—uterine cancer	3.65e-06	0.000294	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CXCL8—uterine cancer	3.49e-06	0.000282	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—HRAS—uterine cancer	3.49e-06	0.000282	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CDKN1B—uterine cancer	3.41e-06	0.000275	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CTNNB1—uterine cancer	3.22e-06	0.00026	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PTEN—uterine cancer	3.14e-06	0.000253	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—AKT1—uterine cancer	3.08e-06	0.000249	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—EP300—uterine cancer	3e-06	0.000241	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—STK11—uterine cancer	2.93e-06	0.000236	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP19A1—uterine cancer	2.93e-06	0.000236	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—VEGFA—uterine cancer	2.84e-06	0.000229	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—NRAS—uterine cancer	2.8e-06	0.000226	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—AKT1—uterine cancer	2.78e-06	0.000224	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—KRAS—uterine cancer	2.41e-06	0.000194	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PIK3CA—uterine cancer	2.22e-06	0.000179	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—MTHFR—uterine cancer	2.2e-06	0.000177	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TP53—uterine cancer	2.14e-06	0.000173	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—HRAS—uterine cancer	2.05e-06	0.000165	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—AKT1—uterine cancer	1.81e-06	0.000146	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PTEN—uterine cancer	1.22e-06	9.87e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—EP300—uterine cancer	1.17e-06	9.41e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PIK3CA—uterine cancer	8.64e-07	6.96e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—AKT1—uterine cancer	7.06e-07	5.69e-05	CbGpPWpGaD
